share_log

Breaking Down Gilead Sciences: 10 Analysts Share Their Views

Breaking Down Gilead Sciences: 10 Analysts Share Their Views

吉利德科学公司解析:10位分析师分享他们的看法
Benzinga ·  12:00
Gilead Sciences (NASDAQ:GILD) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
吉利德科学(纳斯达克:GILD)在上一季度接受了10位分析师的分析,显示了从看好到看淡的各种观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近评级的精简视图,显示了过去30天的不同情绪,并将其与前几个月进行比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.3, a high estimate of $93.00, and a low estimate of $69.00. A 1.68% drop is evident in the current average compared to the previous average price target of $78.62.
分析师评估的12个月目标价值提供了进一步的见解,其中包括77.3美元的平均目标价值,93.00美元的高估价值和69.00美元的低估价值。当前平均价值与之前的平均目标价值78.62美元相比下降了1.68%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级:全面解析
The standing of Gilead Sciences among financial...
仔细分析最近分...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发